Supplementary data for article: Antic, B.; Boskovic, M.; Nikodinovic-Runic, J.; Ming, Y.; Zhang, H.; Bozin, E. S.; Janković, D.; Spasojevic, V.; Vranjes-Djuric, S. Complementary Approaches for the Evaluation of Biocompatibility of 90Y-Labeled Superparamagnetic Citric Acid (Fe,Er)3O4 Coated Nanoparticles. Materials Science and Engineering C 2017, 75, 157–164. https://doi.org/10.1016/j.msec.2017.02.023 by Antić, Bratislav et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary data for article: 
 
        Antic, B.; Boskovic, M.; Nikodinovic-Runic, J.; Ming, Y.; Zhang, H.; Bozin, E. S.; 
Janković, D.; Spasojevic, V.; Vranjes-Djuric, S. Complementary Approaches for the 
Evaluation of Biocompatibility of 90Y-Labeled Superparamagnetic Citric Acid (Fe,Er)3O4 
Coated Nanoparticles. Materials Science and Engineering C 2017, 75, 157–164. 
https://doi.org/10.1016/j.msec.2017.02.023 
 
 
1 
 
Supplementary materials 
Table S1. Lethal and teratogenic effects observed in zebrafish (Danieo rerio) embryos at 
different hours post fertilization. 
Category   Developmental endpoints  
    
    Lethal effect  Egg coagulation a  
  Tail not detached  
  No somite formation  
  No heart-beat  
    
Teratogenic 
effect 
 Malformation of head  
  Malformation of eyes b  
  
Malformation of 
sacculi/otoliths c 
 
  Malformation of chorda  
  Malformation of tail d  
  Scoliosis  
  Yolk deformation  
  Growth retardation e  
a No clear organs structure are recognized 
b Malformation of eyes was recorded for the retardation in eye development and abnormality in  shape and size. 
c Presence of no, one or more than two otoliths per sacculus, as well as reduction and enlargement of otoliths and/or 
sacculi (otic vesicles). 
d Tail malformation was recorded when the tail was bent, twisted or shorter than to control embryos as assessed by 
optical comparation. 
e Growth retardation was recorded by comparing with the control embryos in development or size (before hatching, 
at 24 hpf and 48 hpf) or in a body length (after hatching, at and onwards 72 hpf). 
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Figure S1. Morphological appearance of MRC-5 cells upon treatment with Er005 (25 µg/mL) at 
20 x magnification. 
 
